Johnson Matthey recently expanded its Cambridge facility to add process development and small-scale manufacturing capabilities. Brian Fairley and Antonio Zanotti-Gerosa explain how this will benefit pharmaceutical manufacturing
Sophisticated solid dose formulations for fixed dose combinations – Jean-François Hilaire, Recipharm, explains how CDMOs can help optimise time-to-market
From pharmaceuticals to surgical equipment, every product made by the healthcare industry will be required to have a unique device identification (UDI) number. Richard Pether, Rotech, explains how healthcare suppliers can deal with implementation
Jennifer Mitcham, Catalent Biologics, offers insight into the new generation of antibody drug conjugates and the increasing importance biologics play in the fight against disease
So the pharma landscape continues to evolve. It’s interesting to witness the changes taking place, many of them using technology to improve the way medicine and drugs are administered, monitored and prescribed
EPM looks at company relationships in the pharma sector to see which companies are teaming up for new developments and which companies are ‘taking a break’
Donald Trump has said that “$300 billion could be saved” by making Medicare, the US federal health insurance programme, negotiate drug prices with pharma companies
How Cherwell Laboratories has been assisting Portsmouth Pharmaceutical Manufacturing Unit (PMU) in its environmental monitoring (EM) programme for over 20 years
